Literature DB >> 1379993

Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: comparison between invasive and non-invasive areas.

P Bertrand1, N Girard, B Delpech, C Duval, J d'Anjou, J P Dauce.   

Abstract

We performed quantitative determination of the distribution of hyaluronan (hyaluronic acid, HA) and the HA-binding protein, hyaluronectin (HN), 2 components of the extracellular matrix of tumor desmoplasia, within 71 human breast carcinomas. Results showed that HA and HN were more elevated in tumoral than in non-tumoral adjacent tissue, and that the peripheral invasive area of tumors contained increased levels of HA and HN as compared with the central non-invasive area (p less than 10(-3) and p less than 10(-5) respectively). HN and HA levels of 61 ductal carcinomas were related to the histological grade of tumors; no significant difference was found between grades for HA; HN was found to be significantly lower in grade III than in grade II tumors (p less than 0.01). HA and HN rates were correlated in grade I and grade II tumors and were not correlated in grade III. Mean percentage of HA saturation level by HN for whole tumors was found to be less than 4%, indicating that HA is essentially free of proteins and could be used as a target for cancer diagnosis or therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379993     DOI: 10.1002/ijc.2910520102

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  31 in total

Review 1.  Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.

Authors:  Ki Young Choi; Gurusamy Saravanakumar; Jae Hyung Park; Kinam Park
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-20       Impact factor: 5.268

Review 2.  Extracellular matrix dynamics in cell migration, invasion and tissue morphogenesis.

Authors:  Kenneth M Yamada; Joshua W Collins; David A Cruz Walma; Andrew D Doyle; Shaimar Gonzalez Morales; Jiaoyang Lu; Kazue Matsumoto; Shayan S Nazari; Rei Sekiguchi; Yoshinari Shinsato; Shaohe Wang
Journal:  Int J Exp Pathol       Date:  2019-06-10       Impact factor: 1.925

3.  Secretory products of breast cancer cells upregulate hyaluronan production in a human osteoblast cell line.

Authors:  Nandita Bose; Anna M Masellis
Journal:  Clin Exp Metastasis       Date:  2006-04-27       Impact factor: 5.150

4.  Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look.

Authors:  Clifford J Whatcott; Haiyong Han; Richard G Posner; Galen Hostetter; Daniel D Von Hoff
Journal:  Cancer Discov       Date:  2011-09       Impact factor: 39.397

5.  Hyaluronan activates cell motility of v-Src-transformed cells via Ras-mitogen-activated protein kinase and phosphoinositide 3-kinase-Akt in a tumor-specific manner.

Authors:  Y Sohara; N Ishiguro; K Machida; H Kurata; A A Thant; T Senga; S Matsuda; K Kimata; H Iwata; M Hamaguchi
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

6.  Matrix hyaluronan alters epidermal growth factor receptor-dependent cell morphology.

Authors:  Jeanne M V Louderbough; Jose I Lopez; Joyce A Schroeder
Journal:  Cell Adh Migr       Date:  2010-01-29       Impact factor: 3.405

7.  Isolation and characterisation of a hyaluronan binding protein, hyaluronectin, from human placenta and its colocalisation with hyaluronan.

Authors:  J M Ponting; S Kumar
Journal:  J Anat       Date:  1995-02       Impact factor: 2.610

8.  The hyaluronan receptor for endocytosis mediates hyaluronan-dependent signal transduction via extracellular signal-regulated kinases.

Authors:  Svetlana V Kyosseva; Edward N Harris; Paul H Weigel
Journal:  J Biol Chem       Date:  2008-04-02       Impact factor: 5.157

9.  Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma.

Authors:  H Hock; M Dorsch; U Kunzendorf; Z Qin; T Diamantstein; T Blankenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

10.  Hyaluronan synthesis inhibitor supplements the inhibitory effects of zoledronic acid on bone metastasis of lung cancer.

Authors:  Naohisa Futamura; Hiroshi Urakawa; Eisuke Arai; Eiji Kozawa; Naoki Ishiguro; Yoshihiro Nishida
Journal:  Clin Exp Metastasis       Date:  2013-01-04       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.